Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Joste

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Urology|January 12, 2005
Association between cancer-free survival and telomere DNA content in prostate tumorsColleen A Fordyce, Christopher M Heaphy, Nancy E Joste, et al.
Journal of the National Cancer Institute|March 26, 2009
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United StatesCosette M Wheeler, William C Hunt, Nancy E Joste, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
GPR30: a novel indicator of poor survival for endometrial carcinomaHarriet O Smith, Kimberly K Leslie, Meenakshi Singh, et al.
Molecular Cancer Research : MCR|July 22, 2011
Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissueKristina A Trujillo, William C Hines, Keith M Vargas, et al.
International Journal of Cancer|February 2, 2006
Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumorsChristopher M Heaphy, Marco Bisoffi, Colleen A Fordyce, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2013
A population-based evaluation of cervical screening in the United States: 2008-2011Jack Cuzick, Orrin Myers, William C Hunt, et al.
Gynecologic Oncology|June 30, 2009
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumorsHugo Arias-Pulido, Harriet O Smith, Nancy E Joste, et al.
American Journal of Clinical Pathology|January 16, 2002
Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparationsKenneth R Lee, Teresa M Darragh, Nancy E Joste, et al.
American Journal of Obstetrics and Gynecology|October 8, 2023
Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United StatesCosette M Wheeler, Norah E Torrez-Martinez, Edith Torres-Chavolla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2014
Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancerNancy E Joste, Brigitte M Ronnett, William C Hunt, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Urology|January 12, 2005
Association between cancer-free survival and telomere DNA content in prostate tumorsColleen A Fordyce, Christopher M Heaphy, Nancy E Joste, et al.
Journal of the National Cancer Institute|March 26, 2009
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United StatesCosette M Wheeler, William C Hunt, Nancy E Joste, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
GPR30: a novel indicator of poor survival for endometrial carcinomaHarriet O Smith, Kimberly K Leslie, Meenakshi Singh, et al.
Molecular Cancer Research : MCR|July 22, 2011
Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissueKristina A Trujillo, William C Hines, Keith M Vargas, et al.
International Journal of Cancer|February 2, 2006
Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumorsChristopher M Heaphy, Marco Bisoffi, Colleen A Fordyce, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2013
A population-based evaluation of cervical screening in the United States: 2008-2011Jack Cuzick, Orrin Myers, William C Hunt, et al.
Gynecologic Oncology|June 30, 2009
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumorsHugo Arias-Pulido, Harriet O Smith, Nancy E Joste, et al.
American Journal of Clinical Pathology|January 16, 2002
Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparationsKenneth R Lee, Teresa M Darragh, Nancy E Joste, et al.
American Journal of Obstetrics and Gynecology|October 8, 2023
Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United StatesCosette M Wheeler, Norah E Torrez-Martinez, Edith Torres-Chavolla, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2014
Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancerNancy E Joste, Brigitte M Ronnett, William C Hunt, et al.
Pageof 3